ArticleMolecular and cellular biochemistry2026
Empagliflozin alleviates lipid deposition and inflammation in diabetic kidney disease by downregulating C1QC.
Shaomin Shi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it